|

Superparamagnetic Iron Oxide Clinical Trials

1 actively recruiting trial

Also known as: Magtrace

Pipeline

Phase 2: 1

Top Sponsors

  • Vastra Gotaland Region1

Indications

  • Sentinel Lymph Node1
  • Breast Cancer1
  • Cancer1

Other1 trial

Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.